SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-100106
Filing Date
2020-08-28
Accepted
2020-08-28 15:18:59
Documents
1
Period of Report
2020-08-27

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 1457
  Complete submission text file 0001104659-20-100106.txt   2916
Mailing Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110
Business Address 100 FEDERAL STREET 19TH FLOOR BOSTON MA 02110 6177728515
TEKLA HEALTHCARE INVESTORS (Issuer) CIK: 0000805267 (see all company filings)

IRS No.: 046564285 | State of Incorp.: MA | Fiscal Year End: 0930
SIC: 0000

Mailing Address KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Bailey Jeffrey Allen (Reporting) CIK: 0001500210 (see all company filings)

Type: 3 | Act: 34 | File No.: 811-04889 | Film No.: 201147534